Universal Health and Pharma Private Limited
About Universal Health and Pharma Private Limited
Data last updated:
Universal Health and Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ashoka Lifesciences Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2013PTC249662. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹33 Cr and a paid-up capital of ₹2 Lakh. It is led by directors Vandana Deepak Jaisingh and Vijay Ghanshamdas Gurnani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ft 201 Majestic Shopping Center 2nd Floor 144 J Shankarsheth Marg Girgaum, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2024, the company reported a revenue of ₹82,000, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹19,000 (net margin -23.2%) and EBITDA of -₹19,000 (EBITDA margin -23.2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 49% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Universal Health and Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFt 201 Majestic Shopping Center 2nd Floor 144 J Shankarsheth Marg Girgaum, Mumbai, Maharashtra, India – 400004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Universal Health and Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Universal Health and Pharma Private Limited
FY 2024 filings availableUniversal Health and Pharma Private Limited reported revenue of ₹82,000 (up 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 32% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 49%. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹19,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -23.2% | ||||
| Net Profit Margin | -23.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Universal Health and Pharma Private Limited, buy the company report.
Board of directors of Universal Health and Pharma Private Limited
Universal Health and Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Deepak Jaisingh Also directs: NDL Ventures Limited, Hinduja Realty Ventures Limited, HFL Enterprises Limited and 1 more | Director | 28 Oct 2013 | 13 Years 0 Months | Current |
| Vijay Ghanshamdas Gurnani | Director | 28 Oct 2013 | 13 Years 0 Months | Current |
Peer comparison
Universal Health and Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JV Simplypharma Private Limited | ₹83,681 (FY 2021) | Chikhali, Maharashtra, India | ||||
| Borosilico Life Sciences Private Limited | ₹83,364 (FY 2024) | Ghaziabad, Uttar Pradesh, India | ||||
| Livett International Private Limited | ₹83,185 (FY 2024) | 36.0% | Bhopal, Madhya Pradesh, India | |||
| Lifelong Biological Private Limited | ₹82,791 (FY 2025) | 24.0% | Bangalore, Karnataka, India | |||
| Powderics Process Technologies Private Limited | ₹82,600 (FY 2025) | Vasai, Maharashtra, India | ||||
| Universal Health and Pharma Private Limitedthis company | ₹82,000 (FY 2024) | -₹19,000 | -23.2% | 32.0% | Mumbai, Maharashtra, India | |
| Prolife Biosciences Private Limited | ₹81,983 (FY 2022) | 3027.0% | Ahmednagar, Maharashtra, India | |||
| Care Life Science Private Limited | ₹81,632 (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Moneta Marketing Private Limited | ₹80,893 (FY 2020) | Ahmedabad, Gujarat, India | ||||
| Zexo Pharmaceuticals Private Limited | ₹80,886 (FY 2019) | Noida, Uttar Pradesh, India | ||||
| O2 Pathlabs Private Limited | ₹80,000 (FY 2025) | -98.0% | New Delhi, Delhi, India |
To see the full peer comparison of Universal Health and Pharma Private Limited, buy the company report.
Auditor
Universal Health and Pharma Private Limited is audited by HITESH C SHAH & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HITESH C SHAH & CO | FY 2017 | 134374W |
Shareholding
The shareholding of Universal Health and Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Universal Health and Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Universal Health and Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Universal Health and Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Universal Health and Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Universal Health and Pharma Private Limited, buy the company report.
Recent activity
Universal Health and Pharma Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Abdolrasoul Hossein Dorri Esfahani ceased to be Director on 03 Aug 2016.
Frequently asked questions
Universal Health and Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 2013 (13+ years old) and is registered under CIN U51101MH2013PTC249662.
Universal Health and Pharma has 2 current directors:
- Vandana Deepak Jaisingh - Director
- Vijay Ghanshamdas Gurnani - Director
The latest financial statements of Universal Health and Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Universal Health and Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Universal Health and Pharma is U51101MH2013PTC249662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Universal Health and Pharma was incorporated on 28 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Universal Health and Pharma by revenue are JV Simplypharma Private Limited, Borosilico Life Sciences Private Limited, Livett International Private Limited, Lifelong Biological Private Limited, Powderics Process Technologies Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment).
Abdolrasoul Hossein Dorri Esfahani ceased to be Director on 03 Aug 2016. Vandana Deepak Jaisingh was appointed as Director on 28 Oct 2013. Vijay Ghanshamdas Gurnani was appointed as Director on 28 Oct 2013.
The registered office of Universal Health and Pharma is at Ft 201 Majestic Shopping Center 2nd Floor 144 J Shankarsheth Marg Girgaum, Mumbai, Maharashtra, India – 400004.
Universal Health and Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Universal Health and Pharma is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
